SABCS 2022 Meeting News Welcome Edition - 10

10
2022 SABCS EXHIBITORS
2Unstoppable . . . . . . . . . . . T8
American Association
for Cancer Research . . . .1011
Aarnet Pty . . . . . . . . . . . . . 635
Alamo Breast Cancer
Foundation . . . . . . . . . . . . 920
Agendia, Inc . . . . . . . . . . . . 513
Agilent Technologies . . . . 733
Angle Europe Limited . . . 929
Arvinas, Inc . . . . . . . . . . . . 1031
AstraZeneca . . . . . . . . . . . 607
Biocept . . . . . . . . . . . . . . . . T11
Biofluidica . . . . . . . . . . . . . 426
Biotheranostics,
A Hologic Company . . . . . 801
Bostongene . . . . . . . . . . . . 107
Caris Life Sciences . . . . . 901
Daiichi Sankyo . . . . . . . . . 100
DAVA Oncology . . . . . . . . 1032
Delphinus Medical
Technologies Inc . . . . . . . . . T2
Dignitana . . . . . . . . . . . . . . 429
Dilon Technologies . . . . . .830
Eisai . . . . . . . . . . . . . 406, 422
Elsevier . . . . . . . . . . . . . . . . T6
Encore Medical
Education LLC . . . . . . . . 1007
Epic Sciences . . . . . . . . . . 529
Exact Sciences . . . . . . . . . 613
Fresenius Kabi USA, LLC . . 915
GE Healthcare . . . . . . . . . . 701
Gencove . . . . . . . . . . . . . . . 828
Genentech . . . . . . . . . . . . . 815
Gilead Sciences . . . . 407, 401
Global Breast Cancer
Conference . . . . . . . . . . . . 924
Guardant Health . . . . . . . . 921
Harborside Press . . . . . . . . T3
Labcorp Oncology . . . . . . . T4
Lilly . . . . . . . 201, 207, 301, 715
Lumicell, Inc . . . . . . . . . . . . 625
MacroGenics, Inc . . . . . . . . 832
MD Anderson
Cancer Center . . . . . . . . . 621
Medidata . . . . . . . . . . . . . . 633
Memorial Healthcare
System . . . . . . . . . . . . . . . . . T5
Menarini Silicon
Biosystems . . . . . . . . . . . . 722
Menarini Stemline . . . . . . 414
Merck & Co, . Inc . . . .734, 907
Merit Oncology . . . . . . . . 1016
Metavivor Research
and Support, Inc . . . . . . . . . T9
Mylan Institutional LLC,
A Viatris Company . . . . . 1020
Myriad Genetics . . . . . . . 1001
Natera . . . . . . . . . . . . . . . . 629
Nejm Group . . . . . . . . . . . . 103
NeoGenomics
Laboratories . . . . . . . . . . . 816
Novartis . . . . . . .521, 601, 723
OBI Pharma USA, Inc . . . . 822
Olink Proteomics, Inc . . . .906
OPIS . . . . . . . . . . . . . . . . . . 922
Organon & Co . . . . . . . . . . . 729
Outcomes4me . . . . . . . . . . T7
Oxford University Press . .430
Paige . . . . . . . . . . . . . . . . . . 814
Paxman USA Inc . . . . . . . . 720
Pfizer . . . . . . . . . . . . . 501, 507
Physicians' Education
Resource . . . . . . . . . . . . . . 825
Pillar Biosciences . . . . . . . 821
The Pink Fund . . . . . . . . . . T10
Pink Warrior Advocates . . T12
Preludedx . . . . . . . . . . . . . 105
Puma Biotechnology . . . 1027
Seagen Inc . . . . . . . . . 102, 421
Sermonix
Pharmaceuticals . . . . . . . 307
Simbiosys, Inc . . . . . . . . . . 823
SiParadigm . . . . . . . . . . . . T13
Society of Surgical
Oncology (SSO) . . . . . . . 1028
Spectrum
Pharmaceuticals, Inc . . . 1014
StatLab . . . . . . . . . . . . . . . 732
Survivingbreastcancer
.org . . . . . . . 433
Tempus . . . . . . . . . . . . . . . 807
Tersera Therapeutics . . . . 428
The Pink Fund . . . . . . . . . . T10
Translational Research
in Oncology . . . . . . . . . . . . 717
Varis Health . . . . . . . . . . . . T14
Veracyte . . . . . . . . . . . . . . . 724
Veru Inc . . . . . . . . . . . . . . . . 829
Zeiss . . . . . . . . . . . . . . . . . . 431
Zero Gravity . . . . . . . . . . . 910
Wednesday-Thursday-Friday
10:00 am - 5:00 pm | Hall 2
Daiichi
Sankyo
100
Seagen
102
Lilly
201
ENTRANCE
Lilly
207
103
Nejm
Group
Preludedx Bostongene
105
107
T10
The Pink Fund
Outcomes4me
T7
T9
Metavivor Research
and Support, Inc.
Elsevier
T6
T8
2Unstoppable
Memorial
Healthcare
System
T5
PRODUCT
THEATRE
Lilly
301
Gilead
Sciences
401
Pfizer
501
ENTRANCE
Sermonix
307
Menari
Stemline
406
Eisai
414
Gilead
Sciences
407
Pfizer
507
Agendia,
Inc
513
Eisai
422
Biofluidica Therapeutics
426
428
Tersera
Oxford
University
Press
430
T4
Labcorp
Oncology
Delphinus Medical
Technologies Inc
T2
421
Novartis
521
T3
Harborside
Press
Seagen
Dignitana Zeiss
Biocept
Pink Warrior
Advocates
T12
Survivingbreastcancer.org
429 431 433
T11
SiParadigm
T13
Sciences
Epic
529
Novartis
601
GE
Healthcare
701
Biotheranostics,
A Hologic Co
801
Caris Life
Sciences
901
ENTRANCE
807Tempus
Gravity
Proteomics
Inc
906
Olink
910
Zero
AstraZeneca
607
NETWORKING
LOUNGE
Exact
Sciences
613
715
Lilly
814
Paige
Translational
Research in
Oncology
717
NeoGenomics
Laboratories
816
Genentech
815
Merck
& Co
907
Fresenius Kabi
915
1014
Spectrum
Merit
Oncology
1016
Mylan Institutional,
A Viatris Co
1020
821
Pillar
UT MD Anderson
621
Paxman
USA Inc
720
722
Menarini
Silicon
Biosystems
Lumicell,
Inc
Natera
625
Veracyte
724
629
728
Novartis
723
OBI Pharma
822
Biosciences Simbiosys
823
920
ABCF
922
OPIS
Physicians'
Education
Resource
825
924
GBCC
Organon
& Co
729
T828
Gencove
T14
Varis
8x24TABLE
830
Dilon
Medidata
633
635
Aamet
Pty
StatLab Merck
732
734
733
Agilent
832
Technologies
Technologies MacroGenics
Veru Inc
829
Guardant Health
921
Angle Plc
929
1028
SSO
1031
Arvinas,
Inc
1032
DAVA
Oncology
Myriad
Genetics
1001
Encore Medical
Education, LLC
AACR
1007
1011
Puma
1027
WELCOME EDITION | SABCSMEETINGNEWS . ORG
BEVERAGE
STATION
NETWORKING
LOUNGE
BEVERAGE
STATION
BEVERAGE
STATION
http://www.Survivingbreastcancer.org http://www.breastcancer.org
SABCS 2022 Meeting News Welcome Edition

Table of Contents for the Digital Edition of SABCS 2022 Meeting News Welcome Edition
